MINITRAN Reviews (NITROGLYCERIN)

Average Rating: 5.0 (1 Ratings)

Filter Results

Compare MINITRAN with similar:

 Type: Rx Drug

  

MINITRAN  (NITROGLYCERIN):  This medication is used to prevent chest pain (angina) in people with a certain heart condition (coronary artery disease). Nitroglycerin belongs to a class of drugs known as nitrates. Angina occurs when the heart muscle is not getting enough blood. This drug works by relaxing and widening blood vessels so blood can flow more easily to the heart. This medication will not relieve chest pain once it occurs. It is also not intended to be used just before physical activities (such as exercise, sexual activity) to prevent chest pain. Other medications may be needed in these situations. Consult your doctor for more details.   FDA Approval Date: 1996-08-30 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR MINITRANCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 5  Major depression and Anxiety None Life saver, for Major depression and Anxiety, it is 1 pill with 2 substances , This drug do 3 things,works for. Anti psychotic anti-depression and as sedative. M 36 2 months
3X day
7/8/2017
  

MINITRAN  (NITROGLYCERIN):  This medication is used to prevent chest pain (angina) in people with a certain heart condition (coronary artery disease). Nitroglycerin belongs to a class of drugs known as nitrates. Angina occurs when the heart muscle is not getting enough blood. This drug works by relaxing and widening blood vessels so blood can flow more easily to the heart. This medication will not relieve chest pain once it occurs. It is also not intended to be used just before physical activities (such as exercise, sexual activity) to prevent chest pain. Other medications may be needed in these situations. Consult your doctor for more details.   FDA Approval Date: 1996-08-30 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP